MRI artificial intelligence (AI) image analysis software developer Perspectum has closed on its first round of Series C funding valued at 30.4 million pounds (34.6 million euros), led by Oppenheimer Holdings.
Perspectum said that it will use the funding to scale its U.S. operations, as well as further develop its future software for multi-organ inflammatory conditions and oncology. HealthQuest Capital, the Blue Venture Fund, and British Patient Capital also participated in the funding round.
Based in Oxford, U.K., Perspectum delivers digital technologies that help clinicians provide better care for patients with liver disease, diabetes, and cancer.
